Search the Newsreel

Press Release: BayFirst Announces Impact of Asset Resolution Plan and Restatement of Prior Period Financial Statements

BayFirst Financial Corp. (NASDAQ: BFX) today announced the expected impact of its previously disclosed asset resolution plan, which involves the bulk sale of a significant portion of its small-balance commercial real estate loans. The company expects to record a pre-tax loss of approximately $34.5 …

BayFirst Rallies 16% in a Month: Should You Buy the Stock?

BayFirst Financial Corp. (BAFN) shares have surged 15.9% in the past month, outperforming industry peers, driven by a strengthened capital base, declining funding costs, and a robust Tampa Bay franchise. While the company faces challenges from legacy SBA lending issues, its renewed focus on …

BayFirst Shareholders Approve Key Equity Expansion Measures

BayFirst Financial Corp (BAFN) shareholders approved key equity expansion measures, including authorizing the issuance of common stock upon conversion of Series D and E preferred stock, and increasing authorized common shares from 15 million to 100 million. These approvals enhance the company's financial flexibility. …

Kenneth R. Lehman discloses 42.4% stake in BayFirst Financial Corp (BAFN)

Kenneth R. Lehman has reported a substantial 42.4% beneficial ownership in BayFirst Financial Corp. (BAFN), comprising 11,500,000 shares held both personally and in his Roth IRA. This significant stake was acquired through the exchange of preferred stock, with Lehman intending to join the boards …

BayFirst Financial Corp. Amends Articles of Incorporation and Share Structure in 2026 8-K Filing

BayFirst Financial Corp. filed an 8-K on July 16, 2026, detailing significant changes including Kenneth R. Lehman becoming the largest shareholder with a 42.38% stake after converting preferred stock, and a massive increase in authorized common stock from 5 million to 100 million shares. …

BayFirst Financial (NASDAQ: BAFN) changes control with 42% equity stake

BayFirst Financial Corp. reported a significant change in control after a special shareholders meeting on July 14, 2026. Kenneth R. Lehman exchanged preferred stock for 11,428,000 common shares, representing 42.38% of the company's outstanding common stock, and will join the company's and its bank's …

BayFirst restates financials after identifying material misstatements

BayFirst Financial Corp. will restate its financial statements for 2024, 2025, and Q1 2026 due to previously unidentified deferred origination costs and accrued interest errors totaling $4.9 million. These restatements will adjust net income for 2024 and increase net losses for 2025 and Q1 …

BayFirst Financial to restate results, book $40.1M in charges

BayFirst Financial Corp. announced it would restate financial statements for 2024, 2025, and Q1 2026, booking $40.1 million in charges primarily due to adjustments in its government-guaranteed loan portfolio. The company's stock is down 62% over the past year, and InvestingPro data indicates it …

BayFirst Financial (NASDAQ: BAFN) to restate results after $37M loan review

BayFirst Financial (NASDAQ: BAFN) announced it will restate its financial statements for 2024, 2025, and the first quarter of 2026 due to $37.0 million in loan adjustments and other financial corrections. The company identified $2.8 million in deferred origination costs and $2.1 million in …

Over 7,000 SBA Loans Are Part of BayFirst's Review

BayFirst Financial (NASDAQ: BAFN) has completed quantifying the impact of its asset resolution plan, which includes $37.0 million in loan-related adjustments impacting over 7,000 unguaranteed SBA 7(a) small balance loans. The company will also record a $1.5 million impairment on a non-marketable equity investment …

Bafna Pharmaceuticals FY26 net profit rises to ₹1,109.98 lakh

Bafna Pharmaceuticals promoter confirms no share encumbrance in FY26

Bafna Pharmaceuticals Clarifies Share Price Movement Following Stock Exchange Queries

Bafna Pharmaceuticals Clarifies Recent Share Price Movement as Market-Driven

Bafna Pharmaceuticals Ltd. Share Price Today - Bafna Pharmaceuticals Ltd. Stock Price Live NSE/BSE

Mylan, two Indian companies line up to buy Bafna Pharmaceuticals